252 related articles for article (PubMed ID: 24329543)
1. Asenapine treatment and health-related quality of life in patients experiencing bipolar I disorder with mixed episodes: post-hoc analyses of pivotal trials.
Michalak EE; Guiraud-Diawara A; Sapin C
Curr Med Res Opin; 2014 Apr; 30(4):711-8. PubMed ID: 24329543
[TBL] [Abstract][Full Text] [Related]
2. Effects of asenapine on depressive symptoms in patients with bipolar I disorder experiencing acute manic or mixed episodes: a post hoc analysis of two 3-week clinical trials.
Szegedi A; Zhao J; van Willigenburg A; Nations KR; Mackle M; Panagides J
BMC Psychiatry; 2011 Jun; 11():101. PubMed ID: 21689438
[TBL] [Abstract][Full Text] [Related]
3. Effect of asenapine on manic and depressive symptoms in bipolar I patients with mixed episodes: results from post hoc analyses.
Azorin JM; Sapin C; Weiller E
J Affect Disord; 2013 Feb; 145(1):62-9. PubMed ID: 22868059
[TBL] [Abstract][Full Text] [Related]
4. Effects of asenapine in bipolar I patients meeting proxy criteria for moderate-to-severe mixed major depressive episodes: a post hoc analysis.
Berk M; Tiller JW; Zhao J; Yatham LN; Malhi GS; Weiller E
J Clin Psychiatry; 2015 Jun; 76(6):728-34. PubMed ID: 25612216
[TBL] [Abstract][Full Text] [Related]
5. A 3-week, randomized, placebo-controlled trial of asenapine in the treatment of acute mania in bipolar mania and mixed states.
McIntyre RS; Cohen M; Zhao J; Alphs L; Macek TA; Panagides J
Bipolar Disord; 2009 Nov; 11(7):673-86. PubMed ID: 19839993
[TBL] [Abstract][Full Text] [Related]
6. Asenapine in the treatment of acute mania in bipolar I disorder: a randomized, double-blind, placebo-controlled trial.
McIntyre RS; Cohen M; Zhao J; Alphs L; Macek TA; Panagides J
J Affect Disord; 2010 Apr; 122(1-2):27-38. PubMed ID: 20096936
[TBL] [Abstract][Full Text] [Related]
7. DSM-5 mixed specifier for manic episodes: evaluating the effect of depressive features on severity and treatment outcome using asenapine clinical trial data.
McIntyre RS; Tohen M; Berk M; Zhao J; Weiller E
J Affect Disord; 2013 Sep; 150(2):378-83. PubMed ID: 23712026
[TBL] [Abstract][Full Text] [Related]
8. Asenapine for long-term treatment of bipolar disorder: a double-blind 40-week extension study.
McIntyre RS; Cohen M; Zhao J; Alphs L; Macek TA; Panagides J
J Affect Disord; 2010 Nov; 126(3):358-65. PubMed ID: 20537396
[TBL] [Abstract][Full Text] [Related]
9. Cost-effectiveness of asenapine in the treatment of bipolar I disorder patients with mixed episodes.
Sawyer L; Azorin JM; Chang S; Rinciog C; Guiraud-Diawara A; Marre C; Hansen K
J Med Econ; 2014 Jul; 17(7):508-19. PubMed ID: 24720805
[TBL] [Abstract][Full Text] [Related]
10. Asenapine: a review of its use in the management of mania in adults with bipolar I disorder.
Chwieduk CM; Scott LJ
CNS Drugs; 2011 Mar; 25(3):251-67. PubMed ID: 21323396
[TBL] [Abstract][Full Text] [Related]
11. Asenapine versus olanzapine in acute mania: a double-blind extension study.
McIntyre RS; Cohen M; Zhao J; Alphs L; Macek TA; Panagides J
Bipolar Disord; 2009 Dec; 11(8):815-26. PubMed ID: 19832806
[TBL] [Abstract][Full Text] [Related]
12. Asenapine: Efficacy and safety of 5 and 10mg bid in a 3-week, randomized, double-blind, placebo-controlled trial in adults with a manic or mixed episode associated with bipolar I disorder.
Landbloom RL; Mackle M; Wu X; Kelly L; Snow-Adami L; McIntyre RS; Mathews M; Hundt C
J Affect Disord; 2016 Jan; 190():103-110. PubMed ID: 26496015
[TBL] [Abstract][Full Text] [Related]
13. Randomized, Double-Blind, Placebo-Controlled Trial of Asenapine Maintenance Therapy in Adults With an Acute Manic or Mixed Episode Associated With Bipolar I Disorder.
Szegedi A; Durgam S; Mackle M; Yu SY; Wu X; Mathews M; Landbloom RP
Am J Psychiatry; 2018 Jan; 175(1):71-79. PubMed ID: 28946761
[TBL] [Abstract][Full Text] [Related]
14. Asenapine for schizophrenia and bipolar disorder: a review of the efficacy and safety profile for this newly approved sublingually absorbed second-generation antipsychotic.
Citrome L
Int J Clin Pract; 2009 Dec; 63(12):1762-84. PubMed ID: 19840150
[TBL] [Abstract][Full Text] [Related]
15. Asenapine: a review of acute and extension phase data in bipolar disorder.
McIntyre RS
CNS Neurosci Ther; 2011 Dec; 17(6):645-8. PubMed ID: 20950326
[TBL] [Abstract][Full Text] [Related]
16. A Review of Asenapine in the Treatment of Bipolar Disorder.
Vieta E; Montes JM
Clin Drug Investig; 2018 Feb; 38(2):87-99. PubMed ID: 29067671
[TBL] [Abstract][Full Text] [Related]
17. Effects of olanzapine alone and olanzapine/fluoxetine combination on health-related quality of life in patients with bipolar depression: secondary analyses of a double-blind, placebo-controlled, randomized clinical trial.
Shi L; Namjoshi MA; Swindle R; Yu X; Risser R; Baker RW; Tohen M
Clin Ther; 2004 Jan; 26(1):125-34. PubMed ID: 14996525
[TBL] [Abstract][Full Text] [Related]
18. [Antipsychotics in bipolar disorders].
Vacheron-Trystram MN; Braitman A; Cheref S; Auffray L
Encephale; 2004; 30(5):417-24. PubMed ID: 15627046
[TBL] [Abstract][Full Text] [Related]
19. Post hoc analyses of asenapine treatment in pediatric patients with bipolar I disorder: efficacy related to mixed or manic episode, stage of illness, and body weight.
Findling RL; Earley W; Suppes T; Patel M; Wu X; Chang CT; McIntyre RS
Neuropsychiatr Dis Treat; 2018; 14():1941-1952. PubMed ID: 30122926
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and tolerability of asenapine for acute mania in bipolar I disorder: meta-analyses of randomized-controlled trials.
Vita A; De Peri L; Siracusano A; Sacchetti E;
Int Clin Psychopharmacol; 2013 Sep; 28(5):219-27. PubMed ID: 23719049
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
